Live Breaking News & Updates on Annandale capital

Stay informed with the latest breaking news from Annandale capital on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Annandale capital and stay connected to the pulse of your community

Aptose Biosciences Inc. (NASDAQ:APTO) Sees Large Decline in Short Interest

Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totalling 54,900 shares, a decline of 35.9% from the March 31st total of 85,600 shares. Approximately 0.6% of the company’s stock are sold short. Based on […]

Texas , United-states , Canada , Piper-sandler , Aptose-biosciences , Aptose-biosciences-inc , Annandale-capital , Sigma-planning-corp , Aptose-biosciences-company-profile , Nasdaq , Texas-capital-bank-wealth-management-services-inc , Get-free-report

Aptose Biosciences Inc. (NASDAQ:APTO) Sees Large Decline in Short Interest

Aptose Biosciences Inc. (NASDAQ:APTO) Sees Large Decline in Short Interest
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada , Texas , United-states , Aptose-biosciences , Piper-sandler , Texas-capital-bank-wealth-management-services-inc , Nasdaq , Sigma-planning-corp , Annandale-capital , Aptose-biosciences-inc , Get-free-report , Planning-corp

Aptose Biosciences Inc. (NASDAQ:APTO) Short Interest Down 35.9% in April

Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 54,900 shares, a decline of 35.9% from the March 31st total of 85,600 shares. Based on an average daily trading volume, of […]

Texas , United-states , Canada , Aptose-biosciences , Piper-sandler , Annandale-capital , Texas-capital-bank-wealth-management-services-inc , Nasdaq , Aptose-biosciences-inc , Sigma-planning-corp , Get-free-report , Capital-bank-wealth-management-services-inc

Cullinan Oncology (NASDAQ:CGEM) Reaches New 1-Year High at $21.89

Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) shares reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $21.89 and last traded at $21.36, with a volume of 288839 shares changing hands. The stock had previously closed at $19.25. Analyst Ratings Changes A number of analysts recently […]

United-states , China , William-blair , Corrine-savill , Zurcher-kantonalbank-zurich-cantonalbank , Cullinan-oncology-inc , China-universal-asset-management-co , Securities-exchange-commission , Nasdaq , Sg-americas-securities , Exchange-traded-concepts , Annandale-capital

KeyCorp Boosts Kimbell Royalty Partners (NYSE:KRP) Price Target to $21.00

Kimbell Royalty Partners (NYSE:KRP – Free Report) had its price objective increased by KeyCorp from $20.00 to $21.00 in a report issued on Monday morning, Benzinga reports. They currently have an overweight rating on the energy company’s stock. Several other research analysts have also weighed in on the stock. Truist Financial lowered their target price […]

Canada , Brettg-taylor , Raymond-james , Kimbell-royalty-partners-company-profile , Keycorp , Barclays-plc , Annandale-capital , Godsey-gibb-inc , National-bank , First-command-advisory-services-inc , Kimbell-royalty-partners , Free-report

Kimbell Royalty Partners (NYSE:KRP) PT Raised to $21.00 at KeyCorp

Kimbell Royalty Partners (NYSE:KRP – Free Report) had its target price raised by KeyCorp from $20.00 to $21.00 in a research note published on Monday morning, Benzinga reports. The brokerage currently has an overweight rating on the energy company’s stock. Several other research analysts have also issued reports on KRP. TD Securities reduced their target […]

Canada , Brettg-taylor , Raymond-james , Securities-exchange-commission , Keycorp , Kimbell-royalty-partners-company-profile , National-bank , First-command-advisory-services-inc , Barclays-plc , Godsey-gibb-inc , Annandale-capital , Kimbell-royalty-partners

Aptose Biosciences Inc. (NASDAQ:APTO) Given Consensus Recommendation of "Buy" by Analysts

Shares of Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) have been assigned a consensus recommendation of “Buy” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have updated their coverage on […]

Texas , United-states , Canada , Aptose-biosciences , Piper-sandler , Texas-capital-bank-wealth-management-services-inc , Aptose-biosciences-inc , Nasdaq , Aptose-biosciences-company-profile , Sigma-planning-corp , Annandale-capital , Get-free-report

Aptose Biosciences Inc. (NASDAQ:APTO) Short Interest Up 70.5% in March

Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 85,600 shares, a growth of 70.5% from the March 15th total of 50,200 shares. Currently, 0.9% of the shares of the company […]

Canada , Texas , United-states , Piper-sandler , Aptose-biosciences , Aptose-biosciences-company-profile , Sequoia-financial-advisors , Cetera-advisors , Nasdaq , Citadel-advisors , Aptose-biosciences-inc , Annandale-capital

G&S Capital LLC Has $1.10 Million Stake in iShares MSCI USA Quality Factor ETF (BATS:QUAL)

G&S Capital LLC decreased its holdings in iShares MSCI USA Quality Factor ETF (BATS:QUAL – Free Report) by 7.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,479 shares of the company’s stock after selling 591 shares during the quarter. G&S Capital LLC’s […]

United-states , Sunbelt-securities-inc , S-capital , Keystone-wealth-services , Annandale-capital , Pasadena-private-wealth , Gs-capital , Flagship-harbor-advisors , States-quality-factor , Free-report , Private-wealth

Brokerages Set Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) PT at $24.64

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) has been given a consensus rating of “Buy” by the ten ratings firms that are presently covering the company, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy rating. The average 12-month price target among brokers that have issued a report on the […]

United-states , China , Iovance-biotherapeutics , Piper-sandler , Merrilla-mcpeak , Nasdaq , Comerica-bank , Annandale-capital , Iovance-biotherapeutics-inc , China-universal-asset-management-co , Get-free-report , Marketbeat-ratings